TB Report - WCSH HMIS

Step 1 — Basic Information

Select the reporting department, month, and year before proceeding.

Department *

Month *

Year *

Step 2 — New Bacteriologically Confirmed Pulmonary TB (PTB+)

TB_TX_PTB.1 — All new PTB+ cases detected and enrolled this reporting period, by age and sex.

PTB+Number of bacteriologically confirmed New Pulmonary TB cases detected & enrolled — by age & sex

Age Group	Male	Female
0 – 4 Years
5 – 9 Years
10 – 14 Years
15 – 19 Years
20 – 24 Years
25 – 34 Years
35 – 44 Years
45 – 54 Years
55 – 64 Years
≥65 Years

Step 3 — Clinically Diagnosed P/Neg & New EPTB Cases

TB_TX_PTB.2 and TB_TX_EPTB.1 — both sub-sections by age and sex.

P/NegTB_TX_PTB.2 — Number of clinically diagnosed new pulmonary negative TB cases detected & enrolled — by age & sex

Age Group	Male	Female
0 – 4 Years
5 – 9 Years
10 – 14 Years
15 – 19 Years
20 – 24 Years
25 – 34 Years
35 – 44 Years
45 – 54 Years
55 – 64 Years
≥65 Years

EPTBTB_TX_EPTB.1 — Number of clinically diagnosed & bacteriologically confirmed new EPTB cases detected & enrolled — by age & sex

Age Group	Male	Female
0 – 4 Years
5 – 9 Years
10 – 14 Years
15 – 19 Years
20 – 24 Years
25 – 34 Years
35 – 44 Years
45 – 54 Years
55 – 64 Years
≥65 Years

Step 4 — Relapse TB Cases & Re-treatment

TB_TX_RTB.1 and TB_RETX.1

RelapseTB_TX_RTB.1 — Number of all RELAPSE TB cases detected & enrolled — by age & sex

Age Group	Male	Female
0 – 4 Years
5 – 9 Years
10 – 14 Years
15 – 19 Years
20 – 24 Years
25 – 34 Years
35 – 44 Years
45 – 54 Years
55 – 64 Years
≥65 Years

Re-TxTB_RETX.1 — Tuberculosis Re-treatment cases

Treatment after Relapse — Male

Treatment after Relapse — Female

Failed — Male

Failed — Female

Lost to follow-up — Male

Lost to follow-up — Female

Others — Male

Others — Female

Step 5 — Key Affected Populations & TB Treatment Outcomes

TB_KEY_POP first, then treatment outcomes for PTB+, P/Neg, EPTB, Relapse, and Community/HEW/PPM.

TB_KEY_POPNumber of notified TB cases from key affected population groups during the reporting period

TB_KEY_POP.1 — Health Care Workers (including HEWs)

TB_KEY_POP.2 — Diabetes

TB_KEY_POP.3 — Homeless

TB_KEY_POP.4 — Refugee

TB_KEY_POP.5 — Sero-negative partners of PLHIV

TB_KEY_POP.6 — Miners

TB_KEY_POP.7 — Congregated Settings

TB_KEY_POP.8 — TB Contacts

TB_KEY_POP.9 — Others

PTB+ OutcomesTB_CR_PTB.1 — Treatment outcome of cohort of new bacteriologically confirmed PTB+ cases (same month, previous EFY)

Total number of PTB+ cohort enrolled (same month previous EFY)

TB_CR_PTB.1.1.1 — Cured

TB_CR_PTB.1.1.2 — Completed

TB_CR_PTB.1.1.3 — Lost to follow-up

TB_CR_PTB.1.1.4 — Died

TB_CR_PTB.1.1.5 — Failed

TB_CR_PTB.1.1.6 — Not evaluated

TB_CR_PTB.1.1.7 — Moved to DR TB Register

P/Neg OutcomesTB_CR_PNTB.2 — Treatment outcome of cohort of clinically diagnosed pulmonary TB cases (P/Neg) (same month, previous EFY)

Total number of P/Neg cohort enrolled (same month previous EFY)

TB_CR_PNTB.2.1.1 — Completed

TB_CR_PNTB.2.1.2 — Lost to follow-up

TB_CR_PNTB.2.1.3 — Died

TB_CR_PNTB.2.1.4 — Failed

TB_CR_PNTB.2.1.5 — Not evaluated

TB_CR_PNTB.2.1.6 — Moved to DR TB Register

EPTB OutcomesTB_CR_EPTB.3 — Treatment outcome of cohort of new extra pulmonary TB (EPTB) cases (same month, previous EFY)

Total number of new EPTB cohort enrolled (same month previous EFY)

TB_CR_EPTB.3.1.1 — Completed

TB_CR_EPTB.3.1.2 — Lost to follow-up

TB_CR_EPTB.3.1.3 — Died

TB_CR_EPTB.3.1.4 — Failed

TB_CR_EPTB.3.1.5 — Not evaluated

TB_CR_EPTB.3.1.6 — Moved to DR TB Register

Relapse OutcomesTB_CR_RTB.4 — Treatment outcome of cohort of all Relapse cases (same month, previous EFY)

Total number of all Relapse cohort enrolled (same month previous EFY)

TB_CR_RTB.4.1.1 — Cured

TB_CR_RTB.4.1.2 — Completed

TB_CR_RTB.4.1.3 — Lost to follow-up

TB_CR_RTB.4.1.4 — Died

TB_CR_RTB.4.1.5 — Failed

TB_CR_RTB.4.1.6 — Not evaluated

TB_CR_RTB.4.1.7 — Moved to DR TB Register

Community / HEW / PPMCommunity referral, HEW treatment adherence support & PPM

TB_COMM.1 — Number of all forms TB cases detected and registered on TB unit register who are initially referred by the community

TB_CBTSR.1 — Number of cohort TB patients (all forms) who were successfully treated (cured plus completed) who received support for treatment adherence by HEWs (same month previous EFY)

TB_CBTSR.2 — Total number of patients who started TB treatment in same reporting month of previous year and who received any form of treatment adherence support from Health Extension Workers

TB_DX_PRIV.1 — Number of all forms of TB cases notified with initial referral by PPM sites for TB diagnosis or initiation of TB treatment or treated at PPM site during the reporting period

Step 6 — Contact Investigation & TPT Coverage

TB_CI contact investigation sections first, then TB_TPT preventive therapy.

TB_CI.1.1Total number of contacts with index bacteriologically confirmed pulmonary drug susceptible TB (DS-TB) cases — by age

Total contacts (DS-TB)

TB_CI.1.1.1 — 0–4 Years

TB_CI.1.1.2 — 5–14 years

TB_CI.1.1.3 — ≥15 Years

TB_CI.1.2Total number of contacts with index bacteriologically confirmed DR-TB cases — by age

Total contacts (DR-TB)

TB_CI.1.2.1 — 0–4 Years

TB_CI.1.2.2 — 5–14 years

TB_CI.1.2.3 — ≥15 Years

ScreenedContacts screened for TB (TB_CI_SCR.1 & TB_CI_SCR.2) and screened negative (TB_CI_SCR_N) — by age

Age Group	TB_CI_SCR.1 DS-TB Contacts Screened	TB_CI_SCR.2 DR-TB Contacts Screened	TB_CI_SCR_N DS-TB Screened Negative
0–4 Years
5–14 years
≥15 Years

TB_TPT.1Number of contacts screened negative for TB and put on TB Preventive Therapy (TPT) — by Age Group & Regimen

TB_TPT.1.1 — 0–4 Years

TB_TPT.1.2 — 5–14 years

TB_TPT.1.3 — ≥15 Years

TB_TPT.1.4.1 — 3HP regimen

TB_TPT.1.4.2 — 3RH regimen

TB_TPT.1.4.3 — 6H regimen

TB_TPT.2Cohort of individuals started TPT 12 months prior to the reporting period — by Age Group & Regimen

TB_TPT.2.1.1 — 0–4 Years (cohort)

TB_TPT.2.1.2 — 5–14 years (cohort)

TB_TPT.2.1.3 — ≥15 Years (cohort)

TB_TPT.2.5.1 — 3HP cohort

TB_TPT.2.5.2 — 3RH cohort

TB_TPT.2.5.3 — 6H cohort

TB_IPT.3Number of cohort of individuals that completed TPT treatment among those who started 12 months prior — by Age Group & Regimen

TB_IPT.3.1 — 0–4 Years completed

TB_IPT.3.2 — 5–14 years completed

TB_IPT.3.3 — ≥15 Years completed

TB_IPT.3.4.1 — 3HP completed

TB_IPT.3.4.2 — 3RH completed

TB_IPT.3.4.3 — 6H completed

Step 7 — Molecular Testing, DST & DR-TB Cases Detected

TB_TST-WHO.1, TB_DST.1, TB_DST.2, and all DR-TB detection indicators (TB_DR_DR). Note: FQ DST (TB_DR_DST.1) is entered in Step 8.

TB_TST-WHO.1Number of new & relapse TB patients initially tested using WHO recommended molecular rapid tests (GeneXpert and others) at the time of TB diagnosis — by age & sex

Age Group	Male	Female
0–4 Years
5–14 years
≥15 Years

TB_DST.1Number of notified bacteriologically confirmed TB cases eligible for drug susceptibility testing — by registration type

TB_DST.1.1 — New

TB_DST.1.2 — Previously treated (including relapse)

TB_DST.1.3 — Unknown

TB_DST.2Number of TB cases with drug susceptibility testing result for at least rifampicin — by registration type

TB_DST.2.1 — New

TB_DST.2.2 — Previously treated (including relapse)

TB_DST.2.3 — Unknown

TB_DR_DR.2Number of Hr-TB TB cases — by age & sex

Age Group	Male	Female
<15 Years
≥15 Years

TB_DR_DR.7–22Total Number of confirmed RR only, MDR-TB, Pre-XDR and XDR-TB cases — by age & sex

Type / Age	Male	Female
TB_DR_DR.7 — RR only <15
TB_DR_DR.7 — RR only ≥15
TB_DR_DR.12 — MDR-TB <15
TB_DR_DR.12 — MDR-TB ≥15
TB_DR_DR.17 — Pre-XDR <15
TB_DR_DR.17 — Pre-XDR ≥15
TB_DR_DR.22 — XDR-TB <15
TB_DR_DR.22 — XDR-TB ≥15

Step 8 — DR-TB Treatment Coverage & Outcomes

TB_DR_TX, TB_DR_DST.2–5 (regimen/HIV/registration/diagnosis), then TB_DR_DST.1 (FQ DST), then TB_DR_CTX interim and final outcomes.

Initiating CentreIs the health facility a DR TB Treatment initiating center?

DR-TB Treatment initiating center

TB_DR_TX.1 & .5Number of Hr-TB put on Hr-TB regimen — by HIV status (TB_DR_TX.1) and by Registration Group (TB_DR_TX.5)

TB_DR_TX.1.1 — HIV Positive

TB_DR_TX.1.2 — HIV Negative

TB_DR_TX.1.3 — HIV Unknown

TB_DR_TX.5.1 — New

TB_DR_TX.5.2 — Previously treated with first line drug

TB_DR_TX.5.3 — Previously treated with second line drug

TB_DR_TX.5.4 — Unknown

TB_DR_DST.2–5DR TB cases put on second line treatment — by regimen type, HIV status, registration group, and diagnosis type

TB_DR_DST.2 — By regimen type:

TB_DR_DST.2.1 — Shorter Regimen

TB_DR_DST.2.2 — Longer Regimen

TB_DR_DST.2.3 — Individualized Regimen

TB_DR_DST.3 — By HIV status:

TB_DR_DST.3.1 — HIV Positive

TB_DR_DST.3.2 — HIV Negative

TB_DR_DST.3.3 — HIV Unknown

TB_DR_DST.4 — By registration group:

TB_DR_DST.4.1 — New

TB_DR_DST.4.2 — Previously treated with first line drug

TB_DR_DST.4.3 — Previously treated with second line drug

TB_DR_DST.4.4 — Unknown

TB_DR_DST.5 — By diagnosis type:

TB_DR_DST.5.1 — Bacterologically confirmed Pulmonary DR TB cases

TB_DR_DST.5.2 — Bacterologically confirmed EPTB DR TB cases

TB_DR_DST.5.3 — Clinically Diagnosed DR TB (Pulmonary and EPTB) cases

TB_DR_DST.1DR TB cases (RR/MDR-TB and Hr TB cases) with baseline DST result at least for fluoroquinolone during the reporting month

TB_DR_DST.1.1 — With Susceptibility Result

TB_DR_DST.1.2 — With Resistant Strain

TB_DR_DST.1.3 — Susceptibility Result Unknown

TB_DR_CTX.1–3DR TB Treatment Interim result — cohort of patients registered the same month of the previous year (12 months earlier)

TB_DR_CTX.1 — Total Number of cohort DR-TB cases initiated on second-line anti-TB the same month of the previous year (12 months earlier)

TB_DR_CTX.1.1 — Shorter Regimen cohort

TB_DR_CTX.1.2 — Longer Regimen cohort

TB_DR_CTX.2 — Short-term regimen cohort results (12 months):

TB_DR_CTX.2.1 — Positive

TB_DR_CTX.2.2 — Negative

TB_DR_CTX.2.3 — Died

TB_DR_CTX.2.4 — Lost to follow-up

TB_DR_CTX.2.5 — Not evaluated

TB_DR_CTX.3 — Long-term regimen cohort results (12 months):

TB_DR_CTX.3.1 — Positive

TB_DR_CTX.3.2 — Negative

TB_DR_CTX.3.3 — Died

TB_DR_CTX.3.4 — Lost to follow-up

TB_DR_CTX.3.5 — Not evaluated

TB_DR_CTX.4DR-TB final outcomes — cohorts started 24 or 36 months earlier

TB_DR_CTX.4.1 — Short-term regimen cohort (24 months earlier):

TB_DR_CTX.4.1.1 — Cured

TB_DR_CTX.4.1.2 — Completed

TB_DR_CTX.4.1.3 — Died

TB_DR_CTX.4.1.4 — Failed

TB_DR_CTX.4.1.5 — Lost to follow-up

TB_DR_CTX.4.1.6 — Not evaluated

TB_DR_CTX.4.2 — Long-term regimen cohort (24 months earlier):

TB_DR_CTX.4.2.1 — Cured

TB_DR_CTX.4.2.2 — Completed

TB_DR_CTX.4.2.3 — Died

TB_DR_CTX.4.2.4 — Failed

TB_DR_CTX.4.2.5 — Lost to follow-up

TB_DR_CTX.4.2.6 — Not evaluated

TB_DR_CTX.4.3 — Long-term (standardized and individualized) cohort (36 months earlier):

TB_DR_CTX.4.3.1 — Cured

TB_DR_CTX.4.3.2 — Completed

TB_DR_CTX.4.3.3 — Died

TB_DR_CTX.4.3.4 — Failed

TB_DR_CTX.4.3.5 — Lost to follow-up

TB_DR_CTX.4.3.6 — Not evaluated

Step 9 — Malnutrition Screening & TB/HIV Co-infection

TB_DR_NUT.1, TB_NUT.2, TB_HIV.P, TB_HIV_N, TB_ART.1, TB_NEW_ART.2

TB_DR_NUT.1Number of drug susceptible TB cases screened for Malnutrition during the reporting period

Category	Normal	MAM	SAM
DS-TB cases screened

TB_NUT.2Number of DR TB cases enrolled to second line drugs screened for Malnutrition during the reporting period

Category	Normal	MAM	SAM
DR-TB cases screened

TB_HIV.PTotal number of new and relapse TB patients registered during the reporting period having a documented HIV positive test result — by age & sex

Age Group	Male	Female
<15 Years
≥15 Years

TB_HIV_NTotal number of new and relapse TB patients registered during the reporting period having a documented HIV negative test result — by age & sex

Age Group	Male	Female
<15 Years
≥15 Years

TB_ART.1Total number of HIV-positive new and relapse TB patients who are already on ART — by age & sex

Age Group	Male	Female
0–4 Years
5–14 years
≥15 Years

TB_NEW_ART.2Total number of newly tested HIV positive TB patients who began ART during the reporting month — by age & sex

Age Group	Male	Female
0–4 Years
5–14 years
≥15 Years

Step 10 — Leprosy, AFB & GeneXpert / LF-LAM

Complete all remaining fields then submit the report. LEP_NOT, LEP_CSCR, LEP_DIS, LEP_TX, TB_LB_AFB, TB_LB_GeneXpert, TB_LB_LF-LAM.

LEP_NOT_1LEP_New leprosy cases detected (MB+PB)

Total new leprosy cases detected (MB+PB)

LEP_NOT_.1.1 — New Leprosy cases detected (PB) by age & sex:

Age	Male	Female
<15 Years
≥15 Years

LEP_NOT_.1.1.5 — New Leprosy cases detected (MB) by age & sex:

Age	Male	Female
<15 Years
≥15 Years

Leprosy OtherRelapse, Retreatment & Contact Screening (LEP_CSCR)

LEP_NOT_.1.1.9 — Total relapse Leprosy cases detected

LEP_NOT_.1.1.10 — Total retreatment cases other than relapse

LEP_CSCR.1 — Total number of household contacts of leprosy cases registered

LEP_CSCR.2 — Total number of household contacts of leprosy patients screened for Leprosy

LEP_CSCR.3 — Total number of household contacts diagnosed with Leprosy

LEP_DIS.1New leprosy cases with Grade II disability (MB+PB) — by age & sex

Age	Male	Female
<15 Years
≥15 Years

LEP_TXResult of new leprosy cohort cases registered at 16 months prior to this reporting period

LEP_TX.2 — Registered cohort of MB cases

LEP_TX.3 — Treatment completed MB cases

LEP_TX.4 — Registered cohort of PB cases

LEP_TX.5 — Treatment completed PB cases

TB_LB_AFBTotal Number of AFB tests performed & positive — by Method

TB_LB_AFB.1 — Total AFB tests performed

TB_LB_AFB.1.1 — Ziehl-Neelsen Based

TB_LB_AFB.1.2 — Fluorescent Based

TB_LB_AFB.2 — Total AFB tested positive

TB_LB_AFB.2.1 — Ziehl-Neelsen Based Positive

TB_LB_AFB.2.2 — Fluorescent Based Positive

TB_LB_GeneXpertTotal Number of tests performed using GeneXpert MTB/RIF/Ultra for MTB detection

TB_LB_GeneXpert — Total tests performed

TB_LB_GeneXpert.1 — MTB Detected, Rif Resistance not detected

TB_LB_GeneXpert.2 — MTB Detected, Rif Resistance detected

TB_LB_GeneXpert.3 — MTB not detected

TB_LB_GeneXpert.4 — Others (Error/Invalid/No Result)

TB_LB_LF-LAMTotal Number of tests performed using Lateral Flow Urine Lipoarabinomannan (LF-LAM) assay

TB_LB_LF-LAM — Total tests performed

TB_LB_LF-LAM.1 — Positive

TB_LB_LF-LAM.2 — Negative